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Abstract
Rationale Cardiomyocytes generated from human induced
pluripotent stem cells (hiPSCs) are suggested as the most
promising candidate to replenish cardiomyocyte loss in regen-
erative medicine. Little is known about their calcium homeosta-
sis, the key process underlying excitation-contraction coupling.
Objective We investigated the calcium handling properties
of hiPSC-derived cardiomyocytes and compared with those
from human embryonic stem cells (hESCs).
Methods and Results We differentiated cardiomyocytes from
hiPSCs (IMR90 and KS1) and hESCs (H7 and HES3) with
established protocols. Beating outgrowths from embryoid bodies
were typically observed 2 weeks after induction. Cells in these
outgrowths were stained positively for tropomyosin and sarco-
meric alpha-actinin. Reverse-transcription polymerase chain
reaction studies demonstrated the expressions of cardiac-
specific markers in both hiPSC- and hESC-derived cardiomyo-
cytes. Calcium handling properties of 20-day-old hiPSC- and
hESC-derived cardiomyocytes were investigated using fluores-
cence confocal microscopy. Compared with hESC-derived
cardiomyocytes, spontaneous calcium transients from both lines
of hiPSC-derived cardiomyocytes were of significantly smaller
amplitude and with slower maximal upstroke velocity. Better
caffeine-induced calcium handling kinetics in hESC-CMs
indicates a higher sacroplasmic recticulum calcium store.
Furthermore, in contrast with hESC-derived cardiomyocytes,
ryanodine did not reduce the amplitudes, maximal upstroke and
decay velocity of calcium transients of hiPSC-derived cardio-
myocytes. In addition, spatial inhomogeneity in temporal
properties of calcium transients across the width of cardiomyo-
cytes was more pronounced in hiPSC-derived cardiomyocytes
than their hESC counterpart as revealed line-scan calcium
imaging. Expressions of the key calcium-handling proteins
including ryanodine recptor-2 (RyR2), sacroplasmic recticulum
calcium-ATPase (SERCA), junction (Jun) and triadin (TRDN),
were significantly lower in hiPSC than in hESCs.
Conclusions The results indicate the calcium handling
properties of hiPSC-derived cardiomyocytes are relatively
immature to hESC counterparts.
Keywords Human induced pluripotent stem cells.
Cardiomyocytes.Calcium handling
Introduction
Human induced pluripotent stem cells (hiPSCs) can be
generated from adult human dermal fibroblasts by transduction
of a defined set of transcription factors to reprogram them back
to an equivalent of the early embryonic state [1–4]. hiPSCs,
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remarkable self-renewal capacity and unquestioned potential
to differentiate into genuine cardiomyocytes [5, 6]. Being
genetically identical to donor patients, patient-specific iPSCs
avoid potential immune rejection and do not have the ethical
issues specific to hESCs [3], thereby representing an attractive
cell source for future cardiac regenerative therapy [7].
However, the prerequisite to the ultimate clinical application
is that hiPSC-derived cardiac derivatives display normal
physiological characteristics. Although the electrophysiologi-
cal properties of hiPSC-derived cardiomyocytes have been
reported [5, 6, 8, 9], which are similar to those of hESC-
derived cardiomyocytes and early fetal cardiomycoytes
[7, 10–12], there is paucity of data concerning the calcium
handling properties of hiPSC-derived cardiomyocytes, the key
process underlying the excitation-contraction coupling.
In adult cardiomyocytes, a small calcium influx through L-
type calcium channels during systole triggers a large calcium
release from the internal calcium store, sarcoplasmic reticulum
(SR) through ryanodine receptors (RyR) [13]. Calcium-
induced calcium release (CICR) is the primary mechanism
linking electrical excitation and mechanical contraction in
cardiomyocytes. During diastole, calcium is actively removed
out of cytosol, mainly through SR calcium-ATPase (SERCA)
back into SR and sodium/calcium exchanger out of cells [13].
It has been reported that ESC-derived cardiomyocytes exhibit
immature calcium dynamics due to the underdeveloped SR
and the developmental expression profiles of calcium handling
proteins[10, 11, 14–18]. However, it remains unclear whether
hiPSC-derived cardiomyocytes exhibit similar immaturity in
calcium handling as hESC-derived cardiomyocytes. In fact,
such immaturity may not only result in poor host-graft
electromechanical integration when transplanted into recipient
heart, but also lead to lethal arrhythmias. In this study, we
examined the calcium handling properties of two hiPSC-
(IMR90- and KEVIN-SIU (KS)1-hiPSCs) derived cardio-
myocytes with confocal microscopy in comparison with two
hESC lines (H7- and HES3-hESCs).
Methods
hiPSC and hESC Culture and Cardiac Differentiation
We used hiPSC line, IMR90-iPSCs (iPS (IMR90)-1, clone 1,
WiCell) (WiCell Research Institute, Madison, Wisconsin),
KS1-iPSCs as generated byourgroup infeeder-free condition
[19], and human embryonic stem cell (hESC) line H7- and
HES3-hESCs (National Institutes of Health, NIH code
WA07 & ES03 respectively) (WiCell Research Institute,
Madison, Wisconsin) for these following experiments.
Undifferentiated cells were cultured on Matrigel™ (BD
Biosciences, MA)-coated dishes with mTeSR™ medium
(Stem Cell Technologies, BC, Canada). Cardiac differentia-
tion was performed according to a published protocol [20].
Briefly, cells were dissociated into clumps using 1 mg/ml
Dispase (Invitrogen, CA, USA) and cultured in suspension
using low attachment plates to form embryoid bodies. The
embryoid bodies were transferred onto gelatin-coated plates
in StemPro®-34 medium (Invitrogen, CA, USA) supple-
mented with 2 mM glutamine (Gibco, CA, USA), 4 mM
monothioglycerol (Sigma-Aldrich, St. Louis, MO), 50 μg/ml
ascorbic acid (Sigma-Aldrich, St. Louis, MO) and 0.5 ng/ml
BMP4 (R&D). In addition, the medium was further
supplemented with various cytokines according to the
following sequence: post-plating day 1 to 4, 10 ng/ml
BMP4, 5 ng/ml bFGF, and 3 ng/ml activin A (Stemgent,
CA, USA); post-plating day 4 to 8, 150 ng/ml DKK1 (Gibco
BRL, Karlsruhe, Germany) and 10 ng/ml VEGF; and after
day 8, 150 ng/ml DKK1, 10 ng/ml VEGF (Peprotech, NJ,
USA), and 5 ng/ml bFGF (Peprotech, NJ, USA).
Isolation of hiPSC- and hESC-derived Cardiomyocytes
Differentiated hiPSC- and hESC-embryoid bodies containing
beating outgrowths were micro-surgically dissected using a
glass knife on post-plating day 21 as previously described [14,
21–23]. Beating cells were dissociated in medium containing
1 mg/ml collagenase B and 60 U/ml DNase I (Roche Applied
Sciences Penzberg, Germany) at 37°C for 30 min and were
re-suspended in Kraftbrühe (KB) solution containing 85 mM
KCl, 30 mM K2HPO4,5m MM g S O 4, 1 mM EGTA, 2 mM
Na2-ATP, 5 mM pyruvic acid, 5 mM creatine, 20 mM taurine,
and 20 mM D-glucose at room temperature for 1 h. Cells
were then plated onto 0.1% gelatin-coated glass coverslips
and maintained with culture medium.
Measurement of Cytosolic [Ca
2+]
Cytosolic calcium transients were estimated in isolated cells
using a confocal imaging system (Olympus Fluoview System
version 4.2 FV300 TIEMPO) mounted on an upright
Olympus microscope (IX71) as previously described [14,
16, 17, 24, 25]. Briefly, cells were loaded with 1:1 (v/v)
amount of 20% Pluronic®-F127 (Invitrogen, life technologies)
and 5 μM Fluo-3 AM (Sigma-Aldrich, St. Louis, MO)
dissolved in DMSO with stock concentration of 5 mM for
45 min at 37°C in Tyrode solution containing 140 mM NaCl,
5mMKCl,1mMMgCl2, 1.8 mM CaCl2, 10 mM glucose and
10 mM HEPES at pH 7.4 [14]. Calcium transients of single
cardiomyocytes were recorded with a temporal resolution of
the line scan at 274 frames per second. Sacroplasmic reticular
(SR) calcium load was estimated from peak calcium release
after the addition of caffeine (10 mM). All confocal calcium
imaging experiments were performed within 48 h after
isolation in order to minimize contamination of time-
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Raw data of fluorescence intensity was recorded by area vs.
time mode (XYT) as a line plot, the calibration curve showed
that there is linear relationship between fluo-3 intensity
recorded with calcium concentration up to 630 nM [Ca
2+].
Regarding to line scan images, they are recorded in line vs.
time mode (XT). The data were then quantified as the
background subtracted fluorescence intensity changes nor-
malized to the background subtracted baseline fluorescence
using Image J. Amplitudes, maximal upstroke and decay
velocity of calcium transient were analyzed by Clampfit
version 9.2.0.09. (Axon Instruments, Inc, Foster City, CA).
Reverse Transcription Polymerase Chain
Reaction (RT-PCR)
Total RNA from 2-week old hiPSC- and hESC-embryoid
bodies was extracted with illustra RNAspin Mini kit (GE
Healthcare, Buckinghamshire, UK). Reverse transcription
was then performed using 0.5 μg RNA in a final volume of
20 μl, using QuantiTect® reverse transcription kit (Qiagen,
Hilden, Germany, http://www1.qiagen.com) according to the
manufacturer’s instructions. Details of a panel of cardiac-
specific genes and calcium handling protein genes are
summarized in Table 1. Quantitative PCR analysis was
performed with real-time PCR Detector (Opticon 2 DNA
Engine, MJ Research, Minnesota, USA) using the iQ SYBR
Green Supermix (Bio-Rad Laboratories, Hercules, CA). For
amplification, after initial holds for 5 min at 95°C, 50 cycles
of 95°C for 15 s followed by corresponding annealing
temperature for 30 s and 72°C for 30 s, melt curve
analysis was performed. The relative quantification of
PCR products was performed according to the 2 $$Ct
method, using mouse GAPDH as internal control. Where
$$Ct¼½ðCttarget gene CtGAPDHÞIMR90 iPS group ð Cttarget gene 
CtGAPDHÞH7hES group  .
Statistical Analysis
Continuous variables are expressed as mean ± standard
deviation. Statistical comparisons were performed using Stu-
dent’s t test. Calculations were performed with SPSS (version
14.0). A p-value <0.05 was considered statistically significant.
For additional methodological details, see the expanded
methods section in the data supplement.
Results
Culture and Cardiac Differentiation of hiPSCs
Undifferentiated IMR-90 and KS1-hiPSCs were main-
tained in a feeder-free culture condition as previously
described (Fig. 1)[ 19, 26]. Resembling to undifferenti-
ated H7- and HES3-hESCs, hiPSC colonies expressed a
panel of pluripotency markers including Oct-4, Nanog,
stage-specific embryonic antigen (SSEA)-4, and tumor-
rejection antigen (TRA)-1-60 (Fig. 1a to p). Spontaneous
beating outgrowths were typically observed 14 days after
cardiac differentiation induction in both hiPSC- and
hESC-derived embryoid bodies (Supplemental video 1
and 2). In immunocytochemical analysis of the cardiac-
specific proteins: α-actinin and tropomyosin were abun-
dantly expressed in IMR90- and KS1-hiPSC- and hESC-
derived cardiomyocytes (Fig. 2a–h). The percentages of
nodal-like, atrial-like and ventricular-like cardiomyocytes
were not different significantly between hiPSC- and
hESC-derived cardiomyocytes (Fig. 2i & j). Quantitative
RT-PCR revealed that although the expressions of α-
MHC and Nkx2.5 in two different lines of hiPSC-derived
cardiomyocytes were comparable to those of hESC-
dervied cardiomyocytes, β-MHC, the adult isoform, was
e x p r e s s e di nm u c hl o w e rl e v e li nh i P S C - d e r i v e dc a r d i o -
myocytes (Fig. 2k &l).
Table 1 Primers used for Real-time quantitative RT-PCR
Gene Direction Sequence (5′ to 3′)
Nkx2.5 Forward TTCCCGCCGCCCCCGCCTTCTAT
Reverse CGCTCCGCGTTGTCCGCCTCTGT
α-MHC Forward GTTGGTGTTGGCTTGCTCCTC
Reverse ATCAAGGAGCTCACCTACCAG
β-MHC Forward TGGGGCTTTGCTGGCACCTCC
Reverse GCGGAGGAGCAAGCCAACACC
NCX1 Forward TGTGCATCTCAGCAATGTCA
Reverse TGATGCCAATGCTCTCACTC
RYR2 Forward CGTTCTAACCAGCATCTCATC
Reverse CGAGCAATACAACCTGACC
SERCA2a Forward ACCCACATTCGAGTTGGAAG
Reverse CAGTGGGTTGTCATGAGTGG
CASQ2 Forward GAGCTTGTGGCCCAGGTCCT
Reverse GATCTCCACTGGGTCTTCAA
Junctin Forward GTAAAATGGCATCCCGAGAC
Reverse GGATGATGATGCCAGAGC
Triadin Forward TCAGTTGCTCCACACTGAGC
Reverse CCCATTTACAGACGGGAAAC
GAPDH Forward AGCCACATCGCTCAGACACC
Reverse GTACTCAGCGCCAGCATCG
Nkx2.5 NK2 transcription factor related, locus 5; α-MHC alpha-
myosin heavy chain; β-MHC beta-myosin heavy chain; NCX1 sodium
calcium exchanger-1; RyR2 ryanodine receptor 2; SERCA-2a sarco-
plasmic reticulum calcium ATPase 2a; CASQ2 calsequestrin-2;
GAPDH Glyceraldehyde 3-phosphate dehydrogenase
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Spontaneous Calcium Transient
We then evaluated the calcium handling properties of
hiPSC-derived cardiomyocytes compared with those of
human ESC-derived cardiomyocytes. Like hESC-derived
cardiomyocytes, spontaneous rhythmic calcium transients
were detected in hiPSC-derived cardiomycytes (Fig. 3a).
However, hiPSC-derived cardiomyocytes exhibits more
immature calcium handling properties than hESC counter-
parts (Fig. 3). Specifically, hiPSC-derived cardiomyocytes
generated smaller amplitudes (IMR-90 iPSC-derived car-
diomyocytes: 12.93±0.79 F/Fo, and KS1-iPSC-derived
cardiomyocytes: 9.10±0.78 F/Fo, vs. H7-ESC-derived
cardiomyocytes: 20.28±1.05 F/Fo,a n dH E S 3 - h E S C -
derived cardiomyocytes: 15.79±1.25 F/Fo; p<0.05;
Fig. 3b), slower maximal upstroke (IMR-90 iPSC-derived
cardiomyocytes: 0.02±0.002 F/Fo/s, and KS1-iPSC-derived
cardiomyocytes: 0.013±0.001 F/Fo/s, vs. H7-ESC-derived
cardiomyocytes: 0.03±0.003 F/Fo/s, HES3-hESC-derived
cardiomyocytes: 0.03±0.002 F/Fo/s; p<0.05; Fig. 3c), and
significant slower maximal decay velocity (IMR-90 iPSC-
derived cardiomyocytes: −0.018±0.001, and KS1-iPSC-
derived cardiomyocytes: −0.009±0.001 F/Fo/s, vs. H7-
ESC-derived cardiomyocytes: −0.014±0.001, and HES3-
hESC-derived cardiomyocytes: 0.019±0.002 F/Fo/s; p<0.05;
Fig. 3d) in comparison with hESC-derived cardiomyocytes.
Effects of Caffeine and Ryanodine on Calcium Transients
of hiPSC-derived Cardiomyocytes
To determine whether SR in hiPSC-derived cardiomyocytes
is in fact functional or not, we investigated the effects of
caffeine, a RyR2 opener, and ryanodine, a RyR2 blocker,
on the calcium transients of hiPSC-derived cardiomyocytes.
Figure 4 shows that the application of caffeine (10 mM) via
a perfusion system induced a single large calcium transient
that decayed slowly in both hiPSC-derived cardiomyocytes
Fig. 1 Stem cell pluripotency markers expression in H7-, HES3-hESCs and IMR90-, KS1-hiPSCs. Tra-1-60 (a, e, i & m), Oct4 (b, f, j & n),
SSEA-4 (c, g, k & o) and Nanog (d, h, l & p) and were expressed in both groups of cell lines
Stem Cell Rev and Rep (2011) 7:976–986 979Fig. 2 Cardiomyocytes differentiated from H7-, HES3-hESCs and
IMR90-, KS1-hiPSCs were stained with two typical cardiac markers,
alpha-actinin (a, c, e & g) and tropomyosin (b, d, f & h). The
proportion of nodal-like, atrial-like, and ventricular-like cells in hESC-
and hiPSC-derived cardiomyocytes as determined with action poten-
tial recordings with patch clamp (i &j). Quantitation of gene
expression of cardiac proteins (k & l) in differentiated H7 hESCs vs.
IMR90-iPSCs and HES3 hESCs vs. KS1-iPSCs. Homeobox protein
Nkx-2.5 (Nkx2.5) and α/β-myosin heavy chain (α/β-MHC); Un-
paired t-test was performed between H7 hESC-CMCs and IMR90
iPSC-CMCs as well as HES3 hESC-CMCs and KS1 iPSC-CMCs
(n=3; **p<0.005 and ***p<0.0005)
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with hESC-derived cardiomyocytes, the caffeine-induced
calcium transients in hiPSC-derived cardiomyocytes
exhibited significantly smaller peak amplitudes (IMR-90
iPSC-derived cardiomyocytes: 9.36±1.14 F/Fo, and KS1-
iPSC-derived cardiomyocytes: 3.39±0.57 F/Fo, vs. H7-
ESC-derived cardiomyocytes: 21.23±0.65 F/Fo, and HES3-
hESC-derived cardiomyocytes: 18.31±0.94 F/Fo; p<0.05,
n=10; Fig. 4b) and a slower maximal delay velocity (IMR-
90 iPSC-derived cardiomyocytes: 0.01±0.002 F/Fo/s and
KS1-iPSC-derived cardiomyocytes: 0.001±0.00 F/Fo/s, vs.
H7-ESC-derived cardiomyocytes: 0.023±0.002 F/Fo/s, and
HES3-hESC-derived cardiomyocytes: 0.028±0.01 F/Fo/s;
p<0.05, n=10; Fig. 4c) as well as maximal upstroke (IMR-
90 iPSC-derived cardiomyocytes: −0.003±0.00 F/Fo/s, and
KS1-iPSC-derived cardiomyocytes: −0.001±0.00 F/Fo/s,
vs. H7-ESC-derived cardiomyocytes: −0.007±0.00 F/Fo/s
and HES3-hESC-derived cardiomyocytes: −0.007±0.00
F/Fo/s; p<0.05, n=10; Fig. 4d) .T h ec a f f e i n ei n d u c e d
calcium release in suggested the presence of functional SR
in hiPSC-derived cardiomyocytes; however, the slower
rate of calcium release may imply an impaired calcium
release through RyR. Consistently, the application of
ryanodine (10 μM) resulted in a smaller reduction in
amplitude in hiPSC-derived cardiomyocytes (IMR-90
iPSC-derived cardiomyocytes: 16.75%, and KS1-iPSC-
derived cardiomyocytes: 5.15%, vs. H7-ESC-derived
cardiomyocytes: 47.95%, and HES3-hESC-derived cardi-
omyocytes: 63.18%, p<0.05, n=10) than human ESC-
derived cardiomyocytes (Fig. 5b–d). Taken together, these
observations suggested the presence of functional internal
calcium store with immature calcium release mechanisms.
To further compare the temporal and spatial patterns of
calcium transients of hiPSC-derived and hESC-derived
cardiomyocytes, transverse line-scan images of calcium
transientwereperformed.Aswepreviouslyreportedinmouse
ESC-derived cardiomyocytes [14], both hESC-derived and
hiPSC-derived cardiomyocytes exhibited a U-shape calcium
wave fronts as in typical feature of t-tubule-deficit cardio-
myocytes: the rise of calcium in the periphery was faster than
their cell centers (Fig. 6a and b).
Furthermore, in addition to the rhythmic whole-cell
calcium transient, there were more high-frequency sub-
maximal-amplitude calcium transients observed in hiPSC-
derivedcardiomyocytesthanhumanESC-derivedcardiomyo-
cytes (25% vs. 8.3%, p<0.05, (n=25)). These sub-maximal
Fig. 3 Representative tracing of calcium transients and 2-D calcium
transients in a H7 & HES3 hESC derived cardiomyocytes (H7 &
HES3 hESC-CMCs), IMR90 & KS1 hiPSC derived cardiomyocytes
(IMR90 & KS1 hiPSC-CMCs). b Amplitude, c maximal upstroke
velocity (Vmax upstroke), and d maximal decay velocity (Vmax decay)
of calcium transients in the cardiomyocytes. Unpaired t-test was
performed between H7 or HES3 hES-CMCs and the other two lines of
iPS-CMCs (n=10; n is corresponds to different individual cells
derived from three different experiments) (*p<0.05, **p<0.005 and
***p<0.0005)
Stem Cell Rev and Rep (2011) 7:976–986 981calcium transients represent local calcium events instead of a
whole-cell event. hiPSC-derived cardiomyocytes exhibited
more local calcium events than their human ESC counter-
part, suggesting a less effective calcium induced calcium
release mechanism.
Expression of Calcium Handing Proteins
To decipher the molecular basis for the difference in
calcium handling properties between hiPSC- and hESC-
derived cardiomyocytes, the expressions of three calcium
handling proteins (sodium calcium exchanger-1 (NCX1),
RyR2, and SERCA2a) as well as the three cardiac SR
luminal auxiliary proteins (calsequestrin, junctin, and
triadin), which form a protein complex associated with
RyR2 were quantified (Fig. 6d and e). As shown in
quantitative reverse transcription polymerase chain reaction,
expressions of RyR2 and SERCA2a wassignificantly lower in
two cell lines of hiPSC-derived cardiomyocytes in compared
to hESC counterpart (p<0.0005; n=3) (Fig. 6d). In addition,
among the three cardiac SR luminal auxiliary proteins, the
expression of triadin and junctin were significantly lower in
hiPSC-derived cardiomyocytes compared with hESC-derived
cardiomyocytes (p<0.0005), while no significant differences
in calsequestrin expressions was observed between the two
cell lines (Fig. 6e).
Discussion
In this study, we report the measurement of whole-cell
calcium transients as well as the temporal and spatial
properties of cellular calcium gradients in IMR-90 and
KS1-hiPSC-derived cardiomyocytes and compared with
those of H7- and HES3-hESC-derived cardiomyocytes.
The major two findings are as follow. First, although
hiPSC-derived cardiomyocytes resembling to hESC coun-
terpart express major SR-calcium handling proteins includ-
Fig. 4 Representative tracing of caffeine-induced calcium release in a
H7- & HES3-hESC derived cardiomyocytes (H7 & HES3 hESC-
CMCs), IMR90- & KS1-hiPS derived cardiomyocytes (IMR90 & KS1
hiPSC-CMCs). b Amplitude, c maximal upstroke velocity (Vmax
upstroke), and d maximal decay velocity (Vmax decay) of calcium
transients in the cardiomyocytes. Unpaired t-test was performed
between H7 or HES3 hES-CMCs and the other two lines of iPS-
CMCs (n=10; n is corresponds to different individual cells derived
from three different experiments; *p<0.05, and ***p<0.0001). Arrow
heads indicated the time points that caffeine was added
982 Stem Cell Rev and Rep (2011) 7:976–986ing RyR2, SERCA2a, and NCX-1 and exhibit typical
whole-cell calcium transients that respond to caffeine and
ryanodine, the CICR mechanism appears not as efficient as
that of hESC-derived cardiomyocytes, indicating more
immature SR-calcium handling. Second, in addition to
more immature whole cell calcium transients, the spatial
inhomogeneities in the temporal properties of calcium
transients across the width of cardiomyocytes were more
pronounced in hiPSC-derived cardiomyocytes than hESC
counterpart.
Cardiomyocytes are the cellular workhorse for cardiac
contractile function. Their loss in myocardial infarction is
irreversible due to their limited regenerative capacity and
often results in heart failure. Although cell-based therapy
has been envisioned as a therapeutic strategy to regenerate
myocardium, transplantation of immature cardiomyocytes
results not only poor graft-host integration but may also
lead to potential lethal arrhythmia, [27, 28] thereby
functional characterization of the stem cell-derived cardio-
myocytes represents the crucial first step toward ultimate
clinical application. Recently, the electrophysiological
properties of hiPSC-derived cardiomyocytes have recently
been reported; [5, 6, 8, 9] the calcium handling properties
of hiPSC-derived cardiomyocytes have not been studied in
detail. In fact, the dynamic alteration of cytosolic calcium
concentration plays the central role in cardiac excitation-
contraction coupling. Upon membrane depolarization, the
influx of calcium via L-type calcium channels triggers
calcium release from the internal calcium store, SR via
RyRs, which in turn initiates the mechanical contraction
[13]. After reaching the peak calcium transient, cytosolic
calcium is actively removed from the cytosol, mainly
Fig. 5 Representative tracing of ryanodine sensitive calcium release
in a H7- & HES3-hES derived cardiomyocytes (H7- & HES3-hES
CMCs) and IMR90- & KS1-hiPSC-derived cardiomyocytes (IMR90-
& KS1-hiPS CMCs). b Amplitude, c maximal upstroke velocity (Vmax
upstroke), and d maximal decay velocity (Vmax decay) of calcium
transients in the cardiomyocytes. Unpaired t-test was performed
between two different groups as indicted by arrows in the figure
(n=12; n is corresponds to different individual cells derived from three
different experiments; *p<0.05 and ***p<0.0001)
Stem Cell Rev and Rep (2011) 7:976–986 983through SERCA-2a back into SR and NCX-1 out of cells
[18]. However, it was shown as early as in 2005 by
Dolnikov and co-workers that the functional properties
related to intracellular calcium handling of hESC-derived
cardiomyocytes differ significantly from adult cardiomyo-
cytes due to immature SR capacity [11]. In fact, cardio-
myocytes derived from hESC exhibit immature calcium
handling properties resembling to that of fetal cardiomyo-
cytes, albeit expressing functional SR [22]. Specifically,
hESC-derived cardiomyocytes, though responsive to caf-
feine and ryanodine, exhibited smaller whole-cell peak
amplitude, slower upstroke and decay in calcium transient
in comparison to adult cardiomyocytes [10, 11, 22]. In our
recordings, while spontaneous rhythmic calcium transients
could be readily observed in hiPSC-derived cardiomyo-
cytes, but these calcium transients were of even smaller
amplitude, slower upstroke velocity, and slower reuptake
compared with H7-hESC-derived cardiomyocytes. In addi-
tion, hiPSC-derived cardiomyocytes were less responsive to
the application of ryanodine, indicating immature function-
ing SR relative to hESC counterpart. This may be partly
related to the lower expression levels of major calcium
handling proteins including SERCA2a and NCX-1 in
hiPSC-derived cardiomyocytes.
Fig. 6 Transverse line-scan
confocal of hiPSC- and
hESC-derived cardiomyocytes.
Representative tracings of
temporal and spatial patterns
of calcium transients of hiPSC-
derived cardiomyocytes (a)
and b hESC-derived cardio-
myocytes, c Time delay in the
initial calcium rise between cell
center and cell periphery in
hiPSC- and hESC-derived
cardiomyocytes, and d
Quantitation of gene expression
of calcium handling proteins
of differentiated H7 hES and
IMR90-iPS (a) and HES3 hES
and KS1-iPS (b). The fold of
change was normalized to
the cardiac marker, Nkx2.5
expression. Sodium-calcium
exchanger-1 (NCX-1),
ryanodine receptor 2 (RyR2),
sarcoplasmic recticulum
calcium-Ca
2+ATPase 2a
(SERCA2a), calsequestrin
(CASQ2), junction (Jun) and
triaden (Trd). Unpaired t-test
was performed between
differentiated H7 hESCs vs.
IMR90-iPSCs and HES3 hESCs
vs. KS1-iPSCs (n=3; *p<0.05,
**p<0.005, and ***p<0.0005)
984 Stem Cell Rev and Rep (2011) 7:976–986Furthermore, in adult cardiomyocytes, RyRs are brought
in close proximity to L-type calcium channels at the t-
tubular system, allowing calcium wavefronts to quickly
penetrate to the interior of the cells. In a stark contrast,
ESC-derived cardiomyocytes exhibit spatial inhomogeneity
in temporal properties of calcium transients across the
width of the cells [14, 21]. Specifically, calcium wavefronts
initiate earlier and reach the peak faster at the periphery of
the ESC-derived cardiomyocytes than the center. As a
result, the calcium wavefronts across the width of the cells
as revealed by transverse line scan image typically show a
U-shaped rise with a marked delay in peak between the cell
periphery and the cell center [14, 21]. Recently, this
inhomogeneity in the calcium release wavefront that
reduces the efficacy of the calcium induced excitation-
contraction coupling, have also been demonstrated in adult
cardiomyocytes from failing heart [29–31]. In the present
study, while both hiPSC- and hESC-derived cardiomyo-
cytes exhibited this typical U-shaped rise in calcium
wavefronts across the width of the cells, the delay between
the cell periphery and the cell center was significantly
longer in hiPSC-derived cardiomyocytes than hESC-
counterpart. It has been suggested that this poor coupling
between the calcium influx through L-type calcium chan-
nels and the calcium release from the SR through RyRs is
secondary to the spatial separation of these ultrastructural
organizations due to the lack of t-tubule [14, 21, 29–31]. At
the t-tubule, triadin, a 32 kDa protein together with a set of
interrelated and interacting proteins including junctin and
calsequestrin forms complex with RyRs on the SR and the
juxtaposed L-type calcium channels in the sarcolemma. In
addition to serve as a physical linker between RyRs and L-
type calcium channels, triadin has also been shown to
regulate calcium release via modulating the gating function
of RyRs [32], as well as modifying the SR structure [33]. In
fact, in triadin null hearts, the ablation of triadin results in
significant reduction in junctional SR proteins including
RyR2, calsequestrin, and junctin, and 50% reduction in the
contacts between junctional SR and t-tubules, which
translate into reduced SR calcium release and impaired
negative feedback of SR calcium release [34, 35]. In the
present study, the expression of triadin was significantly
lower in hiPSC-derived cardiomyocytes than that of
hESC counterpart, which may partly explain the imma-
ture whole-cell calcium handling properties as well as the
temporal inhomogeneity in calcium transient. As trans-
plantation of immature cardiomyocytes results not only
poor graft-host integration but also lethal arrhythmia [27,
28], in vitro manipulation of stem cell-derived cardio-
myocytes is needed in order to yield mature cardiomyo-
cytes. Exploiting various hypertrophic stimuli including
triiodonthyronine, ouabain, apoA-I, and hypoxia, we have
previously shown that calcium handling properties of
ESC-derived cardiomyocytes could be driven more
mature (or adult-like) for potential therapeutic use, and
such changes were associated with the upregulation of
major calcium handling proteins such in ESC-derived
cardiomyocytes [16, 17, 24, 25]. The possibility of driven
maturation of hiPSC-derived cardiomyocytes with these
strategies requires further investigation.
Our study is limited by certain technological short-
comings. First, the confocal calcium imaging was not
performed simultaneously with action potential recordings
using patch clamp, thereby the chamber-identity of indi-
vidual cardiomyocytes cannot be ascertained. Second, the
calcium imaging was performed with Fluo-3 instead of
ratiometric calcium indicators like Indo-1 or Fura-2, thus
precluding the possibility of measuring the absolute
intracellular calcium concentration.
Taken collectively, hiPSC-derived cardiomyocytes pos-
sess functional but immature SR. This finding has potential
clinical implication. Although hiPSC-derived cardiomyo-
cytes, avoiding the potential immune rejection and ethic
issues peculiar to hESC, hold promise for cardiac regener-
ation, the immature calcium-handling properties of hiPSC-
derived cardiomyocytes can result in poor functional
integration and/or lethal arrhythmia after cellular transplan-
tation, thus limiting their potential therapeutic applications.
Thereby, it is highly desirable to develop strategies to drive
functional maturation ex vivo.
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